Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANTAGE: Volixibat for cholestatic pruritus in primary biliary cholangitis
CTR20244920Phase 2Active
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of volixibat in primary biliary cholangitis (PBC), sponsored by Mirum Pharmaceuticals, Inc.. Started Aug 2025; status: active.
02
Drugs
volixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on CTR20244920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244920.